Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transactions concern allocation of share options.
For further details, reference is made to Coloplast’s Remuneration Policy. The policy is available on the group website at this address:
https://investor.coloplast.com/investor-relations/governance/policies_and_positions/
| Details of the person discharging managerial responsibilities/person closely associated | |||
| a) | Name | Kristian Villumsen | |
| 2 | Reason for the notification | ||
| a) | Position/status | President & CEO | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN7SOJ5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share options relating to B shares | |
| Identification code | ISIN: DK0060448595 (B shares) | ||
| b) | Nature of the transaction | Share option allocation | |
| c) | Price and volume | Price | Volume |
| 0.00 | 73,690 | ||
| d) | Aggregated information | ||
| – Aggregated volume | 73,690 share options | ||
| – Price | DKK 0.00 | ||
| e) | Date of the transaction | 2025-02-04, 12:10 UTC | |
| f) | Place of the transaction | Outside a trading venue | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Anders Lonning-Skovgaard | |
| 2 | Reason for the notification | ||
| a) | Position/status | Executive Vice President & CFO | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN7SOJ5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share options relating to B shares | |
| Identification code | ISIN: DK0060448595 (B shares) | ||
| b) | Nature of the transaction | Share option allocation | |
| c) | Price and volume | Price | Volume |
| 0.00 | 37,511 | ||
| d) | Aggregated information | ||
| – Aggregated volume | 37,511 share options | ||
| – Price | DKK 0.00 | ||
| e) | Date of the transaction | 2025-02-04, 12:10 UTC | |
| f) | Place of the transaction | Outside a trading venue | |
For further information, please contact
Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111
Aleksandra Dimovska
Vice President, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: dkadim@coloplast.com
Simone Dyrby Helvind
Senior Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2981
Email: dksdk@coloplast.com
Press and media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com
Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917
Website
www.coloplast.com
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.
Coloplast was founded on passion, ambition, and commitment. We were born from a nurse’s wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology and Voice and Respiratory Care.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2025-02.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.
Attachment
Global cybersecurity provider deepens sustainability commitment, aiming to secure a better future for the environment.SEATTLE,…
Following the positive progress announced to the market on the Uprated Connection Agreement and the…
Fingerprint Cards AB (FPC) will host a telephone conference and webcast presentation of its first…
Orrön Energy AB (“Orrön Energy”) will publish its financial report for the first quarter 2025…
Q1 2025 FOR SIILI: Siili continued AI strategy implementation and actions for profitability improvements, revenue…
Image by Andrew Jovic DÜSSELDORF, Germany, April 22, 2025 (GLOBE NEWSWIRE) -- Independent art collector…
This website uses cookies.